Class Action Filed Against Geron Corporation (GERN) - May 12, 2025 Deadline to Join - Contact Levi & Korsinsky
Portfolio Pulse from
A class action lawsuit has been filed against Geron Corporation alleging securities fraud between June 7, 2024 and February 25, 2025. The lawsuit claims the company misled investors about the growth potential and commercial prospects of its drug Rytelo. Following a financial results announcement on February 26, 2025, Geron's stock price dropped 32.07% in a single day, from $2.37 to $1.61 per share.
March 26, 2025 | 2:30 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Geron's stock is under legal scrutiny following a class action lawsuit alleging securities fraud related to its Rytelo drug marketing and growth projections.
The lawsuit and significant stock price decline suggest potential legal and financial challenges for Geron, which could negatively impact investor sentiment and stock performance.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100